We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Drive Medical - DeVilbiss Healthcare

DeVilbiss Healthcare is a world leader in the design, manufacture, and marketing of respiratory medical products, inc... read more Featured Products: More products

Download Mobile App




Worldwide Growth Seen in Respiratory Device Market

By HospiMedica International staff writers
Posted on 07 Apr 2014
The global respiratory device market continues to grow, mainly due to the aging of the world population and increasing incidence of respiratory diseases. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

The bulk of revenue of the USD 47 billion-dollar market, which includes inhalers, oxygen systems, oximeters, and other equipment, is derived from the 36 billion inhaler segment. The segment comprises metered dose inhalers or dry powder versions, which are commonly used for the treatment of asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), or any lung disease characterized by chronic or acute inflammation. They consist of a micronized form of drug in a propellant under pressure with surfactants to prevent clumping of drug crystals.

Other products such as endotracheal tubes, tracheostomy tubes, nasopharyngeal catheters, and oxygen mask devices, which comprise a smaller portion of the market, will see faster growth, since many are disposable and used in hospital or homecare settings. Material innovations are also driving a rising demand in products focusing on comfort and wearability, such as the Devilbiss (Somerset, PA, USA) EasyFit SilkGel Nasal and Full Face Mask, and the Teleflex Softech Plus nasal cannula. The market encompasses many different products to help treat and monitor respiratory conditions, as well as many large and small manufacturers.

“The market for inhalers continues to grow based on the aging of the world population, an increase in respiratory diseases and a general increase in conditions,” said report author Kalorama analyst Mary Anne Crandall. “Because of the ease of use and advancements in inhaler delivery, drug companies and drug delivery manufacturers are increasing interest in this technology.”

According to the report, the device market will grow at a 4.6% compound annual growth rate (CAGR), reaching 59 billion in 2018; revenue growth in the high-demand comfort and wearability products is predicted to be 50% faster than the overall market.

Related Links:

Kalorama Information
Devilbiss



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.